Insmed
INSM
116 hedge funds and large institutions have $1.33B invested in Insmed in 2015 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 56 increasing their positions, 25 reducing their positions, and 22 closing their positions.
124% more repeat investments, than reductions
Existing positions increased: 56 | Existing positions reduced: 25
18% more capital invested
Capital invested by funds: $1.12B → $1.33B (+$205M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3% less funds holding
Funds holding: 119 → 116 (-3)
14% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 22
26% less call options, than puts
Call options by funds: $5.02M | Put options by funds: $6.77M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
+$38.8M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$13.8M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$8.5M |
| 4 |
State Street
Boston,
Massachusetts
|
+$6.89M |
| 5 |
Morgan Stanley
New York
|
+$6.44M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$16.7M |
| 2 |
TCP
Tourbillon Capital Partners
New York
|
-$12.5M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
-$11.7M |
| 4 |
Citigroup
New York
|
-$10.5M |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$8.35M |
INSM Hedge Fund Activity: Q2 2015 in Review
116 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in Insmed (INSM) for Q2 2015, worth a combined $1.33B — up 18% from $1.12B a quarter earlier.
Sellers outnumbered buyers: 22 funds closed out of INSM and 19 opened new positions — a net loss of 3 holders — while 25 trimmed existing stakes and 56 added.
The largest buyer was OrbiMed, opening a new position worth an estimated $38.8M. The largest seller was Deerfield Management, cutting an estimated $16.7M.
- 116 institutional investors held Insmed (INSM) as of Q2 2015, down from 119 in Q1 2015.
- Funds reported $1.33B of Insmed stock for Q2 2015, up 18% quarter-over-quarter.
- 19 funds opened new Insmed positions in Q2 2015 and 22 closed out, a net change of -3 holders.
- The largest Insmed buyer in Q2 2015 was OrbiMed, an estimated $38.8M added.
- The largest Insmed seller in Q2 2015 was Deerfield Management, an estimated $16.7M sold.
Based on aggregated 13F filings for Q2 2015.